Cardinal Health CAH Pharmaceutical and Specialty Solutions — Goodwill, Acquired During Period
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cardinal Health in its filing.
Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.
The official record: Cardinal Health’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cardinal Health's pharmaceutical and specialty solutions — goodwill, acquired during period.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cardinal Health's pharmaceutical and specialty solutions — goodwill, acquired during period?
- Cardinal Health (CAH) reported pharmaceutical and specialty solutions — goodwill, acquired during period of $1.9B in Q4 2025.
- How has Cardinal Health's pharmaceutical and specialty solutions — goodwill, acquired during period changed year-over-year?
- Cardinal Health's pharmaceutical and specialty solutions — goodwill, acquired during period increased by 148.6% year-over-year, from $763M to $1.9B.
- What does pharmaceutical and specialty solutions — goodwill, acquired during period mean?
- The amount of goodwill recognized specifically from business acquisitions completed during the current reporting period within the Pharmaceutical and Specialty Solutions segment. This metric highlights the company's inorganic growth strategy and the premium paid for new assets. It provides insight into the scale and cost of recent expansion efforts.